South African regulator says no major safety concerns from local J&J study
South Africa suspended the rollout of the J&J vaccine in the “implementation study” on Tuesday, after US health agencies recommended pausing its use because of rare cases of blood clots in six people inoculated with it
FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and sryinge are seen in front of displayed Johnson&Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
South Africa's drugs regulator SAHPRA said on Wednesday that it had recently reviewed data from Johnson & Johnson's (J&J) local research study immunising healthcare workers and found no major safety concerns.
SAHPRA added that it was awaiting additional data from J&J and the US Food and Drug Administration.
South Africa suspended the rollout of the J&J vaccine in the "implementation study" on Tuesday, after US health agencies recommended pausing its use because of rare cases of blood clots in six people inoculated with it.
Keep updated, follow The Business Standard's Google news channel
